Select region
Close filter
Board Advisory

Life Sciences Survey 2010

Managerial Competencies in the Generics Sector

The generics industry has entered a phase of radical transformation. Rapid globalization, continuing consolidation, and increasing business complexity have turned formerly regional players into global operations. Rapid R&D, an agile supply chain, and a purely entrepreneurial culture are no longer the only attributes generics companies need in order to succeed. Today these companies find themselves under pressure to develop or acquire the competencies required by new business models and operating realities.

To find out how they see this challenge and how they are meeting it we interviewed 35 executives at 26 companies, including 10 of the largest, as well as mid-size regional and local companies. Our sample was drawn from 11 countries distributed across Asia, Eastern Europe, Western Europe and North America. This wide geographical distribution enabled us not only to develop an international view but also to distinguish the perspectives of headquarters and local subsidiaries.

Topics Related to this Article

Related content

Pharma’s High-Stakes Leadership in Times of COVID-19

Pharma’s High-Stakes Leadership in Times of COVID-19


The pharma and healthcare sector faces a serious threat of operational challenges due to COVID-19. Operations leaders gather to discuss how to move forward. Read more

Hum Work. How We Work and Lead <i>Now</i>.

Hum Work. How We Work and Lead Now.

Leadership Advisory

There is no downplaying the damage wrought by the COVID-19 pandemic on lives, livelihoods, and mental health. Read more

Leading Through the Coronavirus Crisis

Leading Through the Coronavirus Crisis

Leadership Advisory

Top executives share lessons learned from previous crises in the Asia-Pacific region – and how they may help today. Read more

Changing language

Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top